Jennifer Williams McVige (Jennifer McVige, Jennifer W McVige)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Combination Therapy

Respiratory Tract

Top Venues

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Andrew D Hershey, Gabriel Paiva da Silva Lima, Nicola Pannacciulli, Mia Mackowski, Reija Koukakis, Jennifer Williams McVige
Pharmacokinetics and safety of erenumab in pediatric patients with migraine: A phase I, randomized, open-label, multiple-dose study. Clinical and translational science 17 (3) (2024)
Carlyn Patterson Gentile, Scott Rosenthal, Heidi Blume, Reena Gogia Rastogi, Jennifer Williams McVige, Alma Bicknese, Ali Ladak, Harshul Zaveri, Kaitlin Greene, Karen M Barlow
American Headache Society white paper on treatment of post-traumatic headache from concussion in youth. Headache (2024)
Andrew D Hershey, Gabriel Paiva da Silva Lima, Nicola Pannacciulli, Mia Mackowski, Reija Koukakis, Jennifer Williams McVige
Pharmacokinetics and safety of erenumab in pediatric patients with migraine: A phase I, randomized, open-label, multiple-dose study. Clinical and translational science 17 (3) (2024)
Andrew D Hershey, Gabriel Paiva da Silva Lima, Nicola Pannacciulli, Mia Mackowski, Reija Koukakis, Jennifer Williams McVige
Pharmacokinetics and safety of erenumab in pediatric patients with migraine: A phase I, randomized, open-label, multiple-dose study. Clinical and translational science 17 (3) (2024)
Andrew D Hershey, Gabriel Paiva da Silva Lima, Nicola Pannacciulli, Mia Mackowski, Reija Koukakis, Jennifer Williams McVige
Pharmacokinetics and safety of erenumab in pediatric patients with migraine: A phase I, randomized, open-label, multiple-dose study. Clinical and translational science 17 (3) (2024)
Marcy E Yonker, Jennifer Williams McVige, Leonid Zeitlin, Hester Visser
A multicenter, randomized, double-blind, placebo-controlled, crossover trial to evaluate the efficacy and safety of zolmitriptan nasal spray for the acute treatment of migraine in patients aged 6 to 11 years, with an open-label extension. Headache 62 (9) (2022)
Jennifer Williams McVige, Rebecca M Hogan, Clayton M Shanahan, Diane L Amend, Shawn M Ferger
An Open-Label Study Evaluating the Pharmacokinetics and Safety of Diclofenac Potassium for Oral Solution for the Acute Treatment of MWA or MWoA in Pediatric Participants. Headache 60 (9) (2020)